Affimed N.V. buy Laidlaw
Start price
13.06.24
/
50%
€0.55
Target price
13.06.25
€23.22
Performance (%)
-
End price
14.06.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Affimed N.V. | - | - | - |
| iShares Core DAX® | 0.336% | 4.366% | 21.868% |
| iShares Nasdaq 100 | 0.541% | 3.170% | 7.017% |
| iShares Nikkei 225® | 4.048% | 6.727% | 22.855% |
| iShares S&P 500 | 0.795% | 3.281% | 4.698% |
Comments by Laidlaw for this prediction
In the thread Affimed N.V. diskutieren
Affimed (NASDAQ: AFMD) had its price target raised by analysts at Laidlaw from $15.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for AFMD provided by MarketBeat
In the thread Trading Affimed N.V.
Die von Laidlaw gewählte maximale Laufzeit wurde überschritten